Reliability Assessment of Ct Enhancement Rate and Extracellular Volume in Liver Fibrosis Prediction Publisher Pubmed



Salahshour F¹ ; Abkhoo A¹ ; Sadeghia S¹ ; Safaei M² Show Affiliations
Source: BMC Gastroenterology Published:2025

Abstract

Background: Reliable, non-invasive evaluation of liver fibrosis is essential for early disease management. Computed tomography (CT)-based extracellular volume (ECV) fraction and portal venous phase enhancement rate (VP-ER) have shown potential in quantifying mild-to-moderate fibrosis. This study investigates the diagnostic performance of ECV and VP-ER in differentiating non-significant (F0–F1) from significant (F2–F3) fibrosis in biopsy-confirmed patients. Methods: Ninety-three patients (20–72 years, 56.9% male) undergoing liver biopsy and multiphasic CT scans were retrospectively enrolled. Patients with METAVIR F4 cirrhosis or incomplete imaging/pathological data were excluded. Hematocrit levels were obtained on the day of CT. ECV was calculated from differences in liver and aortic attenuation between delayed and enhanced phases, adjusted for hematocrit. VP-ER was derived as the ratio of liver attenuation in venous to portal venous phases multiplied by 100. Spearman’s correlation, receiver operating characteristic (ROC) curves, and DeLong tests evaluated their performance. Multiple logistic regression assessed independent contributions of ECV and VP-ER to fibrosis status. Results: Fifty-three patients had no significant fibrosis (F0–F1) and 40 had significant fibrosis (F2–F3). ECV demonstrated a moderate correlation with fibrosis grade (r = 0.531, p < 0.0001), while VP-ER showed a weaker yet statistically significant correlation (r = 0.363, p = 0.0003). ROC analyses yielded an area under the curve (AUC) of 0.698 for ECV (cut-off = 38%) and 0.763 for VP-ER (cut-off = 71%), with no significant difference between AUCs (p = 0.358). VP-ER accurately classified 70 patients, while ECV correctly predicted 65. Logistic regression revealed significant associations for both VP-ER (OR = 1.08; p = 0.007) and ECV (OR = 1.025; p = 0.0132), achieving 72.04% classification accuracy and an overall AUC of 0.756 (95% CI: 0.688–0.863). Conclusion: ECV fraction and VP-ER demonstrated reliable, complementary capabilities for distinguishing non-significant fibrosis from significant fibrosis. Their combined use in routine multiphasic CT protocols may reduce dependence on invasive biopsy while offering robust sensitivity and specificity for early fibrosis assessment. Further studies including cirrhotic populations and larger cohorts are recommended. © The Author(s) 2025.